• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

AEQUUS PHARMACEUTICALS INC (AQS)

AuthorizedHalted
Sell: 0.005 CAD|Buy: 0.005 CAD|Change: 0 (0%)

Open 

0.005 CAD

Previous close 

0.005 CAD

Trade high 

0.005 CAD

Volume 

100,000

Year high 

0.04 CAD

Year low 

0.005 CAD

Dividend yield 

–

Market capitalisation 

0.66 mn CAD

P/E ratio 

–

ISIN 

CA0076361033

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Share price

Performance

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
AEQUUS PHARMACEUTICALS INC 0
More...

Company profile

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment.The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Sector 

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.